drug
arcotatug tavatecan
Phase 2updated 6mo agoby $TAK TAKEDA PHARMACEUTICAL CO LTD
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(3)
- From RAS rivalries to leaked cancer vaccine readouts, ESMO brought the data dramaEvery ESMO conference is eventful, but the drama kicked into gear earlier than expected this year when the eagerly anticipated phase 3 data for Moderna and Merck & Co.’s cancer vaccine were leaked…fiercebiotech · 19d ago
- ESMO: AstraZeneca exec insists phase 3 ADC data ‘robust’ enough for regulators despite PFS missAn AstraZeneca executive was adamant that detailed data from a phase 3 study of the pharma’s next-generation antibody-drug conjugate are “robust” enough to take to regulators, despite the trial fai…fiercebiotech · 22d ago
- ESMO: Takeda’s $1.2B bet on Innovent ‘absolutely’ pays off with details of ADC’s phase 3 winTakeda has lifted the lid on the phase 3 win for its next-generation claudin18.2 drug, with the antibody-drug conjugate (ADC) demonstrating overall survival of 10.2 months.fiercebiotech · 23d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that